The time has come to lower prescription drug prices in the United States, U.S. Sen. Kirsten Gillibrand, D-NY, said Thursday afternoon at a news conference in Utica.
“As New Yorkers face growing health challenges and economic hardship in the wake of the pandemic, they are being forced to make decisions between picking up their drugs and buying groceries or keeping the lights on,” she said. “And while people struggle to access the medications they need, the five largest pharmaceutical companies in the country are making tens of billions of dollars in profits.”
The pandemic has proven the urgency of the issue, she said, pointing out that prices increased for 860 prescription drugs last year.